Niacinamide Derivative Topical Composition for Prolonged Antimicrobial Protection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current topical compositions for antimicrobial benefits, while generating antimicrobial peptides (AMPs), do not provide sufficient long-lasting protection against harmful microorganisms on human skin, scalp, and oral cavity surfaces.

Innovation Solution

A topical composition containing a compound of formula I, where R is a cycloalkyl group with 4 to 6 carbon atoms, combined with a cosmetically acceptable base, induces the generation of AMPs, providing enhanced antimicrobial benefits and prolonged protection when applied to external human body surfaces.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If existing topical compositions containing niacinamide are used to generate AMPs, then some antimicrobial benefit is achieved, but the protection duration is insufficient and does not last 24 hours

Engineering Contradiction:
Improveprotection durationVSAvoidantimicrobial benefit reliability
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The patent modifies the chemical structure of niacinamide by replacing the amide hydrogen with a cycloalkyl group (4-6 carbon atoms) to create compound of formula I. This structural parameter change enhances the compound's ability to induce AMP generation and extends protection duration to 24 hours or more, resolving the contradiction between protection duration and antimicrobial reliability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses a composite approach by combining the modified niacinamide derivative (compound of formula I) with a cosmetically acceptable base containing emollients, humectants, and preservatives. This composite formulation enhances both the duration and reliability of antimicrobial protection while maintaining skin compatibility.

Inventive Principle:
Principle #40Composite materials

2Reliability

If higher concentrations of niacinamide are used to enhance AMP generation, then antimicrobial benefit improves, but skin tolerance and cosmetic acceptability may deteriorate

Engineering Contradiction:
Improveantimicrobial benefitVSAvoidskin irritation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters of niacinamide by introducing a cycloalkyl substituent at the 5-position, creating compound of formula I. This structural modification increases antimicrobial efficacy through enhanced AMP induction while maintaining skin tolerance, allowing effective concentrations without causing irritation.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional antimicrobial compounds are applied directly to kill microorganisms, then immediate antimicrobial effect is achieved, but the body's natural defense mechanism is not enhanced

Engineering Contradiction:
Improveantimicrobial effectVSAvoidimmunity enhancement duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent employs a self-service mechanism where compound of formula I stimulates the skin's own defense system to produce antimicrobial peptides (psoriasin, defensins, cathelicidins). The body's keratinocytes naturally generate these AMPs in response to the compound, providing sustained immunity enhancement without requiring continuous external antimicrobial application.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The compound of formula I performs preliminary action by pre-stimulating keratinocytes to increase AMP production before microbial invasion occurs. This proactive enhancement of the skin's defense mechanism provides lasting protection, unlike conventional antimicrobials that only act when infection is present.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentEP3727316B1A topical composition based on niacinamide derivative
Publication Date: 2021.10.13 UNILEVER GLOBAL IP LTD
  • EP3727316B1 patent drawing
  • EP3727316B1 patent drawing
  • EP3727316B1 patent drawing

AI summary

The present invention relates to a topical composition comprising a compound of formula (I) wherein R is a cycloalkyl group with the total number of carbon atoms in the cycloalkyl group in the range 4 to 6.